Polen Capital Management »

Aktis Oncology shares owned by Polen Capital Management

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Polen Capital Management from 13F filings

Historical chart of Polen Capital Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Polen Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Polen Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 64k 32.23

More positions owned by Polen Capital Management

Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Amazon (AMZN)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Servicenow (NOW)
Oracle Corporation (ORCL)
Shopify Cl A Sub Vtg Shs (SHOP)
Msci (MSCI)
Lam Research Corp Com New (LRCX)
Starbucks Corporation (SBUX)
IDEXX Laboratories (IDXX)

View all positions for Polen Capital Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology